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Summary
The hyper-IgE syndrome (HIES) is a rare primary im-
munodeficiency characterized by recurrent skin ab-
scesses, pneumonia, and highly elevated levels of serum
IgE. HIES is now recognized as a multisystem disorder,
with nonimmunologic abnormalities of the dentition,
bones, and connective tissue. HIES can be transmitted
as an autosomal dominant trait with variable expressiv-
ity. Nineteen kindreds with multiple cases of HIES were
scored for clinical and laboratory findings and were gen-
otyped with polymorphic markers in a candidate region
on human chromosome 4. Linkage analysis showed a
maximum two-point LOD score of 3.61 at recombi-
nation fraction of 0 with marker D4S428. Multipoint
analysis and simulation testing confirmed that the prox-
imal 4q region contains a disease locus for HIES.
Introduction
Hyper-IgE syndrome (HIES), also called “Job syn-
drome” (MIM 147060) and “hyper-IgE recurrent infec-
tion syndrome” (243700), was first described as a pri-
mary immunodeficiency characterized by recurrent
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staphylococcal skin abscesses, recurrent pneumonia with
pneumatocele formation, eczema, eosinophilia, and
highly elevated levels of serum IgE (Davis et al. 1966;
Buckley et al. 1972; Hill et al. 1974a, 1974b; Dona-
bedian and Gallin 1983; Belohradsky et al. 1987). A
distinctive facial appearance, hyperextensibility of the
joints, bone fractures, and craniosynostosis have been
reported in many cases of HIES (Davis et al. 1966; Kirch-
ner et al. 1985; Cohen 1988; Borges et al. 1998; Holland
and Gallin 1998). Recently, a systematic evaluation of
30 patients established HIES as a multisystem disorder
characterized by susceptibility to infection, elevated lev-
els of serum IgE, eosinophilia, a unique facial phenotype,
retained primary dentition, bone fragility, hyperexten-
sible joints, and scoliosis (Grimbacher et al. 1999a).
Most patients with HIES are sporadic cases. However,
in many kindreds, autosomal dominant transmission,
including male to male transmission, has been reported
(Van Scoy et al. 1975; Blum et al. 1977; Buckley and
Sampson 1981; Kraemer et al. 1981; Dreskin and Gallin
1987; Buckley 1996; Grimbacher et al. 1999a). In ad-
dition, the expressivity of HIES within a kindred can be
highly variable.
Past studies of HIES focused on the immune system.
Investigations targeted IgE production and metabolism
(Buckley and Becker 1978; Buckley et al. 1982; Kraemer
et al. 1982; Ochs et al. 1983; Dreskin et al. 1985, 1987;
Vercelli et al. 1990); granulocyte chemotaxis (Hill et al.
1974a, 1974b; Van Scoy et al. 1975; Van Epps et al.
1983; Gahr et al. 1987); eosinophilia (Buckley and
Sampson 1981; Donabedian and Gallin 1983; Buckley
1996); T-lymphocyte subsets (Geha et al. 1981; Ochs et
al. 1983; Buckley et al. 1991); production of cytokines,
such as interleukin 4 and interferon g (King et al. 1989;
Claassen et al. 1991; Paganelli et al. 1991; Rousset et
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al. 1991); and responsiveness to cytokine-mediated sig-
nals (e.g., via the interleukin-4 or interferon-g receptors)
(Hershey et al. 1997). However, no immunologic defect
has been found consistently in all patients. Moreover,
candidate-gene approaches, to date, have failed to dem-
onstrate linkage of HIES to the locus of the interleukin-
4 receptor on chromosome 16 (Grimbacher et al.
1998a).
Thus, the primary cause of HIES remains unknown.
Our demonstration of the involvement of many systems
in HIES suggests that the gene(s) responsible for HIES
must be involved not only in the regulation of IgE and
inflammation but also in the development and remod-
eling of bone and soft tissue.
To pursue the genetic localization of HIES, affected
individuals and their relatives were evaluated, a quan-
titative-phenotype score was developed, and cytogenetic
analyses were performed. One patient with sporadic
HIES plus autism and mental retardation was found to
have a supernumerary marker chromosome, derived
from a 15–20-cM interstitial deletion in chromosome
4q21 (Grimbacher et al. 1999b). This information
prompted an investigation of linkage of HIES with poly-
morphic markers on chromosome 4. Here, we report
linkage of our multiplex HIES families to the cytoge-
netically identified candidate region on chromosome 4.
Subjects and Methods
Subjects and Families
Forty-four fully affected subjects with HIES and 93
of their relatives, eight of whom were considered to have
a mild form of HIES, were evaluated by physicians of
the National Institutes of Health (NIH; B.G., S.M.H.,
and J.M.P.) in compliance with approved protocols (95-
HG-0066 and 93-I-0119). This cohort was used to de-
velop a phenotypic questionnaire and scoring system.
Twenty-four patients with HIES were from 12 unrelated
multiplex white, Asian, and African American families
(see fig. 1; families 1–7, 9, 15, 17, 20, and 22). The
remaining 20 patients with HIES were sporadic cases.
In addition, multiplex HIES kindreds were sought from
collaborating immunologists, and an additional seven
HIES families were enrolled (see fig. 1; families 10–12,
18, 19, 21, and 24). Families 8, 13–15, and 23 were not
used for linkage analysis, either because there was only
one definite case of HIES or because the second case was
an identical twin of the propositus. Informed consent
was obtained from all subjects or their parents. Histories
were recorded; physical examinations, complete and dif-
ferential blood counts, and IgE determinations were per-
formed; and blood samples for karyotype and DNA
analyses were obtained. DNA was extracted from whole
blood with the Puregene DNA Isolation Kit (Gentra
Systems).
Scoring System
To account for the phenotypic variability in relatives
of propositi with HIES, a scoring system was developed
with use of both clinical and laboratory test criteria (ta-
ble 1). Five of us (J.I.G., B.G., S.M.H., H.L.M., and
J.M.P.) used the literature and recent analysis of 30 pa-
tients with HIES and 70 of their relatives (Grimbacher
et al. 1999a) to assign a point value for each finding,
on the basis of its incidence in HIES and specificity for
HIES. Findings highly specific to HIES were given more
weight than those that are frequent in HIES but that
also are relatively common in the general population.
Individual clinical impressions of the above physicians
were consistent with the following total-point score as-
signments: at 15 points, the subject is likely to carry
an HIES genotype; at 10–14 points, the presence of an
HIES genotype is indeterminate; and at !10 points, the
subject is unlikely to have an HIES genotype. Some of
the clinical findings, such as scoliosis, the characteristic
facies, and retained primary teeth, cannot be ascertained
in children with age !8 years and may first appear during
adolescence. Similarly, the number of episodes of infec-
tions and fractures and the chance of developing pneu-
matoceles in patients with HIES increases as patients get
older. To reflect this diagnostic uncertainty and to avoid
false-negative scores in children, inversely age-dependent
points were assigned to individuals with age !5 years.
This scoring system was validated in 14 additional newly
enrolled NIH patients plus their family members and in
16 patients with HIES and their relatives who were eval-
uated at the Dr. von Haunersches Kinderspital (by
B.H.B. and E.D.R.) (Belohradsky et al. 1987). Scores
within each family were assigned by NIH clinical in-
vestigators before genotypes for that family were
analyzed.
Genotyping
Fluorescent primers for polymorphic markers from
chromosome 4 were purchased from Research Genetics
and PE Applied Biosystems. Genotyping PCR was per-
formed at the conditions specified for each primer set.
PCR results were analyzed on an ABI 377 sequencer (PE
Applied Biosystems) with the COLLECTION and
ANALYSIS software packages (PE Applied Biosystems).
Allele sizes were determined with the help of GENO-
TYPER (PE Applied Biosystems).
Linkage Analysis
For linkage analysis, individuals were assigned to dif-
ferent liability classes on the basis of their clinical score
Figure 1 Pedigrees of multiplex HIES families. Numbers adjacent to pedigree symbols indicate HIES score (see table 2). Blackened symbols indicate a score of 15 (classification of “affected”);
striped symbols indicate a score of 10–14 (classification of “unknown”); unblackened symbols indicate a score of 0–9 (classification of “unaffected”); and a slash indicates a deceased family member.
Table 1
Scoring System with Clinical and Laboratory Tests for Individuals in Kindreds with HIES
CLINICAL FINDINGS
POINTSa
0 1 2 3 4 5 6 7 8 10
Highest serum-IgE level (IU/ml)b !200 200–500 501–1,000 1,001–2,000 12,000
Skin abscesses None 1–2 3–4 14
Pneumonia (episodes over lifetime) None 1 2 3 13
Parenchymal lung anomalies Absent Bronchiectasis Pneumatocele
Retained primary teeth None 1 2 3 13
Scoliosis, maximum curvature !10 10–14º 15–20 120
Fractures with minor trauma None 1-2 12
Highest eosinophil count (cells/ml)c !700 700–800 1800
Characteristic face Absent Mildly present Present
Midline anomalyd Absent Present
Newborn rash Absent Present
Eczema (worst stage) Absent Mild Moderate Severe
Upper respiratory infections per year 1-2 3 4–6 16
Candidiasis None Oral Fingernails Systemic
Other serious infections None Severe
Fatal infection Absent Present
Hyperextensibility Absent Present
Lymphoma Absent Present
Increased nasal widthe !1 SD 1–2 SD 12 SD
High palate Absent Present
Young-age correction 15 years 2–5 years 1–2 years 1 year
a The entry in the furthest-right column is assigned the maximum points allowed for each finding.
b Normal !130 IU/ml.
c 700/ml = 1SD, 800/ml = 2 SD above the mean value for normal individuals.
d For example, cleft palate, cleft tongue, hemivertebrae, other vertebral anomaly, etc. (see Grimbacher et al. 1999a).
e Compared with age- and sex-matched controls (see Farkas et al. 1994).
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Table 2
Liability-Class Assignment on the Basis of HIES Phenotypic
Score
CLINICAL
POINT
SCORE PHENOTYPE
PENETRANCEa
w/w w/m m/m
61 Affected .00 .999 .999
51–60 Affected .01 .99 .99
41–50 Affected .02 .98 .98
31–40 Affected .03 .97 .97
21–30 Affected .05 .95 .95
18–20 Affected .10 .90 .90
15–17 Affected .20 .80 .80
10–14 Unknown ) ) )
8–9 Unaffected .80 .20 .20
6–7 Unaffected .90 .10 .10
4–5 Unaffected .98 .02 .02
0–3 Unaffected .99 .01 .01
) Married in, unaffected .999 .00 .00
) Unavailable, unknown ) ) )
a Fractions represent likelihood of autosomal dominant
HIES genotypes. Abbreviations: “w/w” = homozygous wild
type, “w/m” = heterozygous wild type/mutant, and “m/m”
= homozygous mutant. (In conventional LINKAGE notation,
the three probabilities for scores of 0–9 would be in the
reverse order.)
(table 2). Linkage calculations were done with FAST-
LINK version 4.0P (Cottingham et al. 1993; Scha¨ffer et
al. 1994), a faster version of LINKAGE 5.1 (Lathrop et
al. 1984), and with FASTSLINK (Ott 1989; Weeks et
al. 1990; Cottingham et al. 1993). Most of the analyses
were done in individuals assigned to penetrance classes
as shown in table 2. We assumed that all founders who
married into families in which the disease was already
present could not be carrying the disease allele. The pen-
etrance values in table 2 were assigned on the basis of
the method advocated by Terwilliger and Ott (1994) for
a disease in which there is significant diagnostic uncer-
tainty. For example, in the affected class with penetrance
values of 0.1, 0.9, and 0.9, we were 90% certain of a
diagnosis of an HIES genotype. In some analyses, we
applied alternative boundaries between the two classes
with the highest clinical score. The disease-allele fre-
quency was set at 1#106, on the basis of the empirical
estimation that the number of fully affected cases in the
United States and Europe appears to be in the low 100s.
Allele frequencies were estimated with the ILINK pro-
gram of FASTLINK. Two-point analyses were done with
the MLINK and ILINK programs of FASTLINK. Mul-
tipoint analyses were done with the LINKMAP program,
on the basis of intermarker recombination fractions (v)
estimated by ILINK. Locus-heterogeneity tests were
done with the MULTIHOMOG program of the ANA-
LYZE package (Terwilliger 1995).
Maps and Marker Loci
We determined the order of the polymorphic markers
by comparing maps and marker loci from the following
databases: Genemap’98, Whitehead Institute for Bio-
medical Research-MIT Center for Genome Research,
and Research Genetics Inc. (Stewart et al. 1997). ILINK
was used to establish the likely marker order in our data
set.
Results
Application of the Scoring System
The clinical and laboratory scoring system (table 1)
was applied to all available members of the 19 families
enrolled in this study. Although the theoretical maxi-
mum HIES score is 109, the most-severely affected pro-
band achieved a score of 79 (fig. 1, family 5). Of 91
individuals at risk to inherit an HIES genotype (see fig.
1), 46 had scores of 114 points and were given a clas-
sification of “affected,” with various penetrance classes
(table 2). Seven subjects had scores of 10–14 and were
given a classification of “unknown.” Thirty-eight had
scores of !10 and were given a classification of “unaf-
fected.” These numbers, although derived solely from
clinical and laboratory data for each individual, reflect
the expected segregation of an autosomal dominant
trait.
Linkage Analysis
Table 3 shows the two-point LOD scores for each of
18 polymorphic markers on chromosome 4, compared
with a dominant HIES phenotype as defined in table 2.
The maximum LOD score of 3.61 was achieved with
marker D4S428 at . Approximately 0.4 of this totalv = 0
LOD score was a result of fortuitous genotypes in fam-
ilies 3 and 15 at marker D4S428; these two families have
lower scores at all nearby markers. Therefore, we ex-
pected multipoint LOD scores with marker D4S428 to
be somewhat lower than 3.6. Table 4 shows represen-
tative maximum point-point LOD scores of ∼3.4. These
multipoint calculations were done with two of the more
informative markers (D4S1547 and D4S1627) on the
proximal side of D4S428 and with three of the more
informative markers (D4S3248, D4S2638, and D4S398)
on the distal side. The maximum multipoint LOD score
was near 3.4 regardless of which flanking markers were
used. Figure 2 shows a graph of representative multi-
point LOD scores, in this case with more-widely spaced
markers D4S405, D4S428, and D4S1534. As expected,
an analysis in affecteds only gave positive LOD scores
in this region, but with values !1.5, indicating a lack of
power.
The two-point results from our data set were sensitive
to the choice of the penetrances because each family was
small, there were few affected individuals, and the di-
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Table 3
Two-Point Linkage Analysis of HIES with Markers on Chromosome 4
MARKER
DISTANCE
FROM
4PTEL
(IN CM)a
LOD SCORE AT v =
MAXIMUM
LOD
SCORE vmax.00 .01 .05 .10 .20
D4S405 56 1.88 1.88 1.84 1.70 1.26 1.88 .012
D4S2919 57 .86 .89 .94 .92 .73 .94 .065
D4S1547 60 2.13 2.08 1.91 1.68 1.22 2.13 .000
D4S1627 60 2.65 2.62 2.48 2.25 1.67 2.65 .000
D4S401 60 .41 .42 .41 .39 .31 .42 .021
D4S1577 61 1.26 1.27 1.28 1.23 1.02 1.28 .034
D4S2996 62 1.06 1.07 1.08 1.04 .87 1.08 .039
D4S1630 63 2.25 2.20 2.03 1.81 1.32 2.25 .000
D4S428 63 3.61 3.54 3.26 2.89 2.10 3.61 .000
D4S3000 67 .94 1.05 1.29 1.36 1.20 1.36 .102
D4S1592 68 .91 1.01 1.18 1.19 .94 1.21 .075
D4S3248 72 1.28 1.35 1.44 1.39 1.08 1.44 .055
D4S2638 72 1.54 1.63 1.76 1.73 1.40 1.77 .064
D4S398 72 2.53 2.48 2.27 2.00 1.43 2.53 .000
D4S2367 77 .64 .75 .96 1.02 .86 1.02 .095
D4S392 78 .98 1.07 1.24 1.26 1.06 1.27 .084
D4S1534 95 2.13 1.23 .29 .16 .46 .47 .234
D4S423 100 1.26 .95 .42 .15 .06 .09 .276
a Distances are from Broman et al. (1998).
Table 4
Four-Point Linkage Analysis of HIES to Markers on
Chromosome 4
Markers Used
Maximum Four-Point
LOD Score
D4S1547-D4S428-D4S3248 3.46
D4S1547-D4S428-D4S2638 3.39
D4S1547-D4S428-D4S398 3.39
D4S1627-D4S428-D4S3248 3.41
D4S1627-D4S428-D4S2638 3.41
D4S1627-D4S428-D4S398 3.40
agnosis was usually not very certain in all family mem-
bers. Indeed, roughly half the families showed no LOD
score outside the range (0.01–0.01), because the phe-
notype score dictated assignment to penetrance classes
with considerable diagnostic uncertainty. Table 5 shows
how the maximum two-point LOD score with marker
D4S428 changed as we varied the lowest affected phe-
notype score assigned to penetrance values of 0.00,
0.999, and 0.999. Moreover, table 5 suggests that several
of the families with peak clinical scores !60 may not be
linked to chromosome 4, although formal tests of locus
heterogeneity were inconclusive.
Because the maximum LOD score was not much
above the standard threshold of 3.0, and because the
maximum LOD score was sensitive to the choice of the
penetrance, we also used simulation to test the signifi-
cance of the scores generated by our data. There were
10 families in our collection (families 1–5, 10, 15, 18,
19, and 22) that exhibited a two-point LOD score with
an absolute value of0.01. We used FASTLINK to gen-
erate marker data for 7,000 replicates of these 10 fam-
ilies in which phenotypes and penetrances were as in
table 2, and genotypes were assigned at random for one
unlinked marker having exactly the allele frequencies we
estimated for marker D4S428. For each of the 7,000
replicates, we computed the two-point LOD score at
, in increments of 0.01. Then we asked, howv = 0.0–0.1
often did the best of these LOD scores for a replicate
exceed various thresholds? The results of this test are
shown in table 6. The maximum LOD score for the
unlinked replicates never reached the observed multi-
point LOD score of 3.46 or the observed two-point LOD
score of 3.61. In fact, the highest LOD score obtained,
by any unlinked replicate, was ! 3.1. To assess the sig-
nificance of seeing zero unlinked replicates in 7,000 with
LOD scores 13.46, we used the method of Ott (1991).
Let X be a binomial random variable with probability
p of success, such that X is the event of having a LOD
score 13.46 in an unlinked replicate. In this represen-
tation, we observed zero successes in 7,000 binomial
trials. The upper boundary of a 95% confidence interval
for the estimate of p is ! .0005.
Linkage calculations in our family data were also per-
formed with a model of recessive inheritance, with a
carrier frequency of .001 corresponding to the assumed
incidence of HIES of 1/106. The LOD scores for most
of the 18 markers were negative, but of a magnitude
sufficiently small to exclude only the hypothesis that all
families are linked to 4q with recessive inheritance. No
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Figure 2 Four-point linkage analysis of HIES. LOD scores were
calculated at the points shown, and linear interpolation was used in
between.
Table 5
Variation in Maximum Two-Point LOD Score
for Marker D4S428 Depending on Boundary
between the Two Most Extreme Affected
Liability Classes
Lowest Phenotype Score
Assigned to Penetrance
Values of .00, .999,
and .999
Maximum
LOD Score v
63 3.37 .0
59–62 3.61 .0
56–58 3.61 .0
54–55 2.79 .05
53 2.32 .08
50–52 2.41 .08
49 2.01 .128
48 1.93 .144
conclusions could be made about the likelihood of re-
cessive inheritance in individual families.
Discussion
Analysis of known immunologic pathways has failed
to elucidate the nature of the underlying defect in HIES.
Candidate-gene approaches, to date, have been unsuc-
cessful (Hershey et al. 1997; Grimbacher et al. 1998),
and positional cloning was not previously feasible be-
cause of the lack of multiplex kindreds with this primary
immunodeficiency, due to early fatality in the era before
effective antibiotic treatment. We have collected 19 mul-
tiplex HIES kindreds, enabling us not only to study the
phenotype and genetics of the disease (Grimbacher et al.
1999a) but also to conduct genetic-linkage studies as
presented here.
The observation of a cytogenetic anomaly, an inter-
stitial deletion and marker-chromosome formation in
chromosome 4q, in a sporadic HIES patient with mental
retardation and autism (Grimbacher et al. 1999b)
prompted us to conduct a limited linkage study in this
region of chromosome 4. Here, we report linkage of our
HIES families to chromosome 4 with a maximum mul-
tipoint LOD score 13.4, with significance confirmed by
simulation.
To assign the individuals enrolled in the present link-
age study to penetrance classes, we developed a scoring
system, on the basis of fully affected patients and their
relatives, using clinical data and laboratory tests. This
system assigns the most points to findings specific to
HIES, such as failure of dental exfoliation, serum-IgE
levels 110,000 IU/ml, or pneumatocele formation. Find-
ings of HIES that are also common in the general pop-
ulation, such as recurrent upper respiratory infections,
serum-IgE levels !500–1,000 IU/ml, or eczema, received
fewer points. This scoring system was validated in newly
enrolled NIH patients and in an independent HIES co-
hort in Germany.
Using this model, we were able to demonstrate linkage
of HIES in our families to the candidate region on chro-
mosome 4. At most of the loci, seven of the families
(families 1–5, 10, and 19) contributed positive two-point
LOD scores 1 0.01, and three of the families (families
15, 18, and 22) contributed negative two-point LOD
scores !0.01, giving a hint of locus heterogeneity. For
small pedigrees, such as those reported here, and for
small recombination fractions, the absolute value of neg-
ative scores in families inconsistent with tight linkage
tends to be much larger than the absolute value of the
positive scores in families consistent with linkage. This
explains why the LOD scores decreased as the criteria
for diagnostic certainty were relaxed (table 5). As the
threshold for certain diagnosis was lowered, from 63 to
48 points, more families contributed notable positive
and negative scores, but the negative scores were much
larger in absolute value at small recombination fractions.
In such a circumstance, and with a maximum LOD score
! 4, it is mathematically impossible to establish locus
heterogeneity by the inference procedure of HOMOG/
MULTIHOMOG (Terwilliger and Ott 1994; Terwilliger
1995). This is because the inference procedure dampens
the effect of the small positive scores by a larger fraction
than does the effect of the larger (in absolute value)
negative scores.
Many families did not contribute LOD scores of an
absolute value0.01 because of the combination of few
cases in the family, diagnostic uncertainty, and low dis-
ease-allele frequency. Nonetheless, our multipoint LOD
scores 13.4 exceeded the standard genomewide signifi-
cance threshold of 3.0. One could argue for a much
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Table 6
Number of Unlinked Replicates of
7,000 Giving a Maximum Two-Point
LOD Score Exceeding Various
Thresholds
Threshold No. Exceeding Threshold
3.1 0
3.0 1
2.5 3
2.0 7
1.5 34
1.0 130
.5 373
.0 897
smaller LOD-score threshold in this circumstance, in
which only a small candidate interval was tested. More-
over, we confirmed the significance of the two-point
scores by a simulation in which none of 7,000 unlinked
replicates reached a two-point LOD score 3.1.
Since we were led to suspect chromosome 4q as a locus
for HIES because of a cytogenetic abnormality in one
patient with sporadic HIES, it is necessary to ask how
the linkage region compares with the interval involved
in the interstitial deletion and marker-chromosome for-
mation in 4q21. Such analysis is complicated by the fact
that it is invalid to define boundaries for a linkage region
by use of recombinants when the penetrance classes have
two-way uncertainty, as ours do. The location of the
maximum LOD score with D4S428 is ∼8 cM above the
proximal boundary of the interstitial deletion and is,
therefore, outside the marker chromosome (Grimbacher
et al. 1999b). A primary reason for this discrepancy is
a recombination in family 1, in the daughter who had
a clinical score of 25 (fig. 1). This 4-year-old girl was
given a diagnosis of HIES because of her newborn rash,
moderate eczema, eosinophil count of 940/ml, and se-
rum-IgE level of 10,375 IU/ml (table 1). Although she
may not be affected with HIES, despite these suggestive
clinical and laboratory findings, it is also possible that
she is affected, but that there is locus heterogeneity. In
this case, the cause of HIES in family 1 would not be a
mutation at the HIES locus on 4q. The discrepancy
might also be explained by long-range effects on the
expression of genes, located in the vicinity of D4S428,
by control regions disrupted during the marker-chro-
mosome formation.
Numerous genes have been mapped near D4S428, in-
cluding c-kit and VEGFR-2, and 150 genes are mapped
to the 15–20-cM region involved in the interstitial de-
letion and marker-chromosome formation of the spo-
radic patient described above (Grimbacher et al. 1999b).
However, on the basis of available functional informa-
tion for these genes, there is no clear candidate gene for
HIES.
Nonetheless, our new appreciation of the multisystem
nature of the disease suggests that there are undiscovered
links between the immune system and the connective-
tissue and skeletal systems. Understanding the molecular
pathology of HIES will shed light not only on inflam-
matory mechanisms, wound healing, and IgE regulation,
but also on development of the face and midline struc-
tures, regulation of bone density, and aspects of con-
nective tissue and dental exfoliation. Pursuit of disease
gene(s) for HIES may lead to diagnostic and therapeutic
approaches for individuals with this rare disease. More-
over, this information may also benefit patients with
more-common medical problems related to the patho-
genic mechanisms in HIES.
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